Search Orphan Drug Designations and Approvals
-
Generic Name: | cridanimod |
---|---|
Date Designated: | 01/12/2011 |
Orphan Designation: | Treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Xenetic Biosciences, Inc. 99 Hayden Avenue Suite 230 Lexington, Massachusetts 02421 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-